Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of an Angiotensin Receptor Blocker in Aortic Stenosis
2018-004653-24Phase 2Active
- Sponsor
- University Hospital Odense
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of losartan in aortic stenosis (AS), sponsored by University Hospital Odense. Primary endpoint: Rate of progression of peak aortic velocity. Started Dec 2019; status: active.
02
Drugs
losartan
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on 2018-004653-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004653-24.